Skip to main content
. 2021 Apr 26;9(1):e002091. doi: 10.1136/bmjdrc-2020-002091

Figure 4.

Figure 4

Glyoxal treatment leads to lipid vesicle accumulation independently of AMPK. The assays were performed on fibroblasts from three different donors. Control: untreated cells; glyoxal: 0.6 mM; AICAR: 1 mM; glyoxal+AICAR: 0.6 mM glyoxal+1 mM AICAR. (A) Western blot analysis of AMPKα and P-AMPKα and measurement of the P-AMPKα/AMPKα ratio. (B) BODIPY 493/503 fluorescence in green, anti-PLIN2 staining in red, and nuclear DAPI staining in blue (scale bare=20 µm). (C) The mean number of lipid vesicles per cell for each fibroblast donor. The LDs were counted randomly (≥50 cells were counted per condition). A t-test is indicated in (A). One-way ANOVA is indicated in (C). **p<0.01; ns=non-significant. The data represent means±SD. AICAR, 5-aminoimidazole-4-carboxamideribonucleotide; ANOVA, analysis of variance; DAPI, 4',6-diaminido-2-phenylindole; LD, lipid droplet.